Alto Neuroscience Stock Soars After FDA Grants Fast Track Designation To Schizophrenia Drug

Retrieved on: 2025-10-03 16:30:34

Tags for this article:

Click the tags to see associated articles and topics

Alto Neuroscience Stock Soars After FDA Grants Fast Track Designation To Schizophrenia Drug. View article details on hiswai:

Excerpt

Shares of Alto Neuroscience (ANRO) soared 54% on Friday afternoon after the company announced that the U.S. Food and Drug Administration granted ...

Article found on: stocktwits.com